{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:40:31Z","timestamp":1794609631529,"version":"4.9.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the InPedILD trial, nintedanib had an acceptable safety profile in children and adolescents (aged 6\u221217 years) with fibrosing ILDs. The open\u2010label extension of the InPedILD trial, InPedILD\u2010ON, is assessing the longer\u2010term safety of nintedanib in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who completed the InPedILD trial on treatment and had a transition period of \u226412 weeks entered InPedILD\u2010ON as \u201crollover patients.\u201d Patients who completed the InPedILD trial and had a transition period of &gt; 12 weeks, and new patients aged 6\u221217 years with fibrosing ILDs, entered InPedILD\u2010ON as \u201cnew patients.\u201d All patients received open\u2010label nintedanib in InPedILD\u2010ON.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty\u2010eight patients received nintedanib in InPedILD\u2010ON. At baseline, mean (SD) age was 13.7 (3.2) years, and FVC was 59.4 (21.6) % predicted. At this data snapshot, median exposure to nintedanib in InPedILD\u2010ON was 61.5 weeks. Diarrhea was the most frequent adverse event, reported at a rate of 50.4 per 100 patient\u2013years. Seven patients discontinued nintedanib, one for each of the following reasons: adverse event (weight decrease), change of residence, burden of study procedures, pregnancy planning, clinical deterioration, other treatment option available, no reason given. Mean (SE) change in FVC % predicted at Week 52 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926) was \u22121.0 (1.4). Mean (SE) change in SpO\n                      <jats:sub>2<\/jats:sub>\n                      (%) on room air at rest at Week 52 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930) was 0.3 (0.8).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The adverse event profile of nintedanib in InPedILD\u2010ON was generally consistent with that reported in the InPedILD trial, supporting the tolerability of nintedanib in children and adolescents with fibrosing ILDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ppul.71707","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:56:07Z","timestamp":1782111367000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD\u2010ON"],"prefix":"10.1002","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-3466","authenticated-orcid":false,"given":"Robin","family":"Deterding","sequence":"first","affiliation":[{"name":"Section of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics University of Colorado Denver Denver Colorado USA"},{"name":"The Children's Hospital Colorado Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Sleep Medicine, The Children's Hospital of Philadelphia Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-9342","authenticated-orcid":false,"given":"Emily M.","family":"DeBoer","sequence":"additional","affiliation":[{"name":"Section of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics University of Colorado Denver Denver Colorado USA"},{"name":"The Children's Hospital Colorado Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Warburton","sequence":"additional","affiliation":[{"name":"Maria Fareri Children's Hospital, New York Medical College, Boston Children's Health Physicians, Valhalla  New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Research, University of Edinburgh Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Schwerk","sequence":"additional","affiliation":[{"name":"Clinic for Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School Hannover Germany"},{"name":"German Center for Lung Research Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Brown","sequence":"additional","affiliation":[{"name":"National Jewish Health Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"Kouck\u00fd","sequence":"additional","affiliation":[{"name":"Motol University Hospital and 2nd Faculty of Medicine, Charles University Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Weinman","sequence":"additional","affiliation":[{"name":"The Children's Hospital Colorado Aurora Colorado USA"},{"name":"Department of Radiology University of Colorado School of Medicine Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Simmons","sequence":"additional","affiliation":[{"name":"Vanderbilt Children's Hospital Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Dumistracel","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Ingelheim am Rhein  Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Jantzen","sequence":"additional","affiliation":[{"name":"mainanalytics GmbH Sulzbach (Taunus) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gahlemann","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim (Schweiz) GmbH Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-912X","authenticated-orcid":false,"given":"Matthias","family":"Griese","sequence":"additional","affiliation":[{"name":"Hauner Children's Hospital, Ludwig Maximilians University, German Center for Lung Research (DZL)  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the InPedILD\u2010ON trial investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30117-8"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26568"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-221772"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0544CI"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091312"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207349"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-221325"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00161-2019"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_2_11_13_1","volume-title":"Ofev EPAR: Summary of Product Characteristics","year":"2025"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01512-2022"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26882"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9703051"},{"key":"e_1_2_11_17_1","unstructured":"Food and Drug Administration. OFEV (nintedanib) Pharmacology\/Toxicology NDA\/BLA Review and Evaluation. 2014 www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/205832Orig1s000PharmR.pdf."},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-015-0276-5"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217331"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-01974-2"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02454-9"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02399-2"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210519"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219434"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02160-2023"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.71707","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.71707","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.71707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:31:40Z","timestamp":1782473500000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.71707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/ppul.71707"],"URL":"https:\/\/doi.org\/10.1002\/ppul.71707","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71707"}}